Profil
Hong Jun Liang is Director at Fuzhou Maixin Biotech Co., Ltd. since 2020.
Formerly, Mr. Liang was Chairman-Supervisory Board at Shanghai Shyndec Pharmaceutical Co., Ltd., Vice Chairman at Beijing Strong Biotechnologies, Inc. from 2020 to 2023, and Director at Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2018 to 2020.
Postes actifs de Hong Jun Liang
| Sociétés | Poste | Début |
|---|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Engages in production, research & development and sales and focus on tissue-based diagnostics specifically IHC antibodies, reagents and the automation of IHC and ISH | Directeur/Membre du Conseil | 15/09/2020 |
Anciens postes connus de Hong Jun Liang
| Sociétés | Poste | Fin |
|---|---|---|
| JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD | Directeur/Membre du Conseil | 01/01/2020 |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Président | 15/11/2019 |
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for treatment of cancer | Health Technology |
Shanghai Shyndec Pharmaceutical Co., Ltd.
Shanghai Shyndec Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and other chemicals | Health Technology |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Engages in production, research & development and sales and focus on tissue-based diagnostics specifically IHC antibodies, reagents and the automation of IHC and ISH | Health Services |
Beijing Strong Biotechnologies, Inc.
Beijing Strong Biotechnologies, Inc. Medical SpecialtiesHealth Technology Develops and sells in-vitro diagnostic instruments | Health Technology |
















